Showing results (391-400 of 9,927) with videos related to

Sort By:
Pageof 993
Plos One|July 26, 2023
How to optimize dust pollution control in opencast coal mines: Analysis of a joint social regulation model based on evolutionary game theoryXu Lian, Wensheng Wang, Jianmin Zhang
Genes & Diseases|July 3, 2023
Targeting SAMHD1: To overcome multiple anti-cancer drugs resistance in hematological malignanciesTao Wang, Ping Liu, Jianmin Yang
Sensors (Basel, Switzerland)|July 29, 2023
Optimized Design of Touching Parts of Soil Disinfection Machine Based on Strain Sensing and Discrete Element SimulationJianmin Gao, Yuhao Shen, Benlei Ma
Frontiers in Immunology|February 23, 2026
Dupilumab treatment outcomes in bullous pemphigoid: a systematic review and single-arm meta-analysisYudi Chen, Kailv Sun, Jianmin Chang
The Neurologist|April 2, 2026
Kimura's Disease Complicated by Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: A Case Report and Review of the LiteratureYuerong Wu, Xuelian You, Jianmin Qiu
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 4, 2026
Integrated single-cell and bulk RNA sequencing reveals regulated necrosis-associated heterogeneity in pancreatic cancerLei Feng, Jianmin Zhang, Zhonghui Zhu
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 30, 2014
[A comparable analysis of IPSS and IPSS-R for evaluating prognosis of myelodysplastic syndrome]Ye Lei, Xiaoqian Xu, Jianmin Yang, et al.
Annals of Hematology|January 5, 2019
Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 yearsYing Zhang, Yimin Zhang, Qi Chen, et al.
Journal of Hematology & Oncology|August 1, 2009
A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from ChinaJianmin Wang, Shuqing Lü, Jianmin Yang, et al.
International Journal of Hematology|December 17, 2008
Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experienceShuqing Lü, Jianmin Wang, Xiaoqian Xu, et al.
Pageof 993